Kronos Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Kronos Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- Kronos Bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$18M, a 44% increase year-over-year.
- Kronos Bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$111M, a 13.1% increase year-over-year.
- Kronos Bio, Inc. annual Operating Income (Loss) for 2023 was -$122M, a 11.1% increase from 2022.
- Kronos Bio, Inc. annual Operating Income (Loss) for 2022 was -$137M, a 9.43% increase from 2021.
- Kronos Bio, Inc. annual Operating Income (Loss) for 2021 was -$151M, a 161% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)